Prenatal Testing for Down Syndrome

Author: Children's Hospital Boston
Published: 2009/09/14 - Updated: 2023/12/19
Publication Type: Informative
Topic: Cognitive Disabilities - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: Prenatal tests for Down syndrome promising to be safer more accurate and available to women earlier in pregnancy. More women will be going through the testing process, which could lead to a lot of difficult, uncomfortable conversations between physicians and expectant parents.

Introduction

New article examines the influence of current tests on birth rates, assesses forthcoming tests, and calls for the establishment of medical and educational policies.

Main Item

Understanding Implications of Prenatal Testing for Down Syndrome

With new prenatal tests for Down syndrome on the horizon promising to be safer, more accurate, and available to women earlier in pregnancy, the medical community must come together and engage in dialog about the impact of existing and expected tests, argues a new leading article published Online First by Archives of Disease in Childhood.

Authored by Brian Skotko, MD, MPP, clinical genetics fellow at Children's Hospital Boston, the article shows a steady decrease in the number of babies being born with Down syndrome since the introduction of prenatal testing and poses the question: "As new tests become available, will babies with Down syndrome slowly disappear"?

Research reviewed by Skotko showed a 15% decrease in births of babies with Down syndrome between 1989 and 2005 in the United States. In the absence of prenatal testing, researchers would have anticipated the opposite - a 34% increase in births - due to the trend of women waiting longer to have children; known to increase the chances of having a baby with Down syndrome.

Currently, expectant women have two options if they would like to receive a definitive diagnosis of Down syndrome - chorionic villus sampling (CVS) and amniocentesis - both of which are invasive and carry a risk, however small, of causing a spontaneous miscarriage. New tests expected to be introduced next year will offer a simple blood test that poses no risk to the fetus and delivers a definitive diagnosis of one or more of the genetic variants of Down syndrome - trisomy 21, translocation, or mosaicism.

Prior research conducted by Skotko found that expectant mothers who received a prenatal diagnosis felt their physicians provided them with incomplete, inaccurate, and oftentimes offensive information about the condition. Other studies have shown physicians themselves feeling unprepared and uninformed to deliver a diagnosis.

"Unless improvements are made prior to the arrival of new prenatal tests, a true collision is on its way," says Skotko. "More women will be going through the testing process, which could lead to a lot of difficult, uncomfortable conversations between physicians and expectant parents."

In anticipation of these tests, which could make Down syndrome the first genetic condition to be definitively diagnosed in the first trimester on a population basis, Skotko calls on the medical community to:

Recently, the National Down Syndrome Society and the National Down Syndrome Congress announced the selection of a booklet "Understanding a Prenatal Down Syndrome Diagnosis" as a gold standard packet of information about Down syndrome, fulfilling Skotko's second recommendation.

"The ultimate goal is to ensure families receive accurate, up-to-date, information so they are well-informed and can make decisions that are right for them," says Skotko.

Attribution/Source(s): This quality-reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by Children's Hospital Boston and published on 2009/09/14, this content may have been edited for style, clarity, or brevity. For further details or clarifications, Children's Hospital Boston can be contacted at childrenshospital.org NOTE: Disabled World does not provide any warranties or endorsements related to this article.

Explore Similar Topics

- After adjusting for diabetes and restricting the age of first stroke to 40, the associations remained significant.

- Researchers have discovered a neurodevelopmental disorder linked to mutations in a single gene (RNU4-2), impacting tens of thousands of individuals globally.

Citing and References

Founded in 2004, Disabled World (DW) is a leading resource on disabilities, assistive technologies, and accessibility, supporting the disability community. Learn more on our About Us page.

Cite This Page: Children's Hospital Boston. (2009, September 14 - Last revised: 2023, December 19). Prenatal Testing for Down Syndrome. Disabled World (DW). Retrieved April 18, 2025 from www.disabled-world.com/disability/types/cognitive/prenatal-testing-down-syndrome.php

Permalink: <a href="https://www.disabled-world.com/disability/types/cognitive/prenatal-testing-down-syndrome.php">Prenatal Testing for Down Syndrome</a>: Prenatal tests for Down syndrome promising to be safer more accurate and available to women earlier in pregnancy.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.